Literature DB >> 9094859

Hepatitis B and C infection among drug abusers in Nepal.

S M Shrestha1, D M Shrestha, T E Gafney, K G Maharjan, F Tsuda, H Okamoto.   

Abstract

Prevalence of hepatitis B and C virus infection amongst intravenous drug users (IDU) in Nepal is not known. To estimate such prevalence 72 IDU individuals were tested for HBV and HCV markers. About 80% of the drug abusers are both anti-HBc (59/72) and anti-HCV (58/72) sero-positive. However persistent infection with hepatitis B, as indicated by positive HBsAg, was detected in only 5.5% (n = 4). Active hepatitis C infection, as indicated by HCV RNA positivity, was documented in 74% (42/58) of those who were anti-HCV positive. Importance of awareness of this observation among the healthcare workers in the prevention of hepatitis C in the community is stressed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9094859

Source DB:  PubMed          Journal:  Trop Gastroenterol        ISSN: 0250-636X


  5 in total

1.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16

2.  Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal.

Authors:  Hans-Tilmann Kinkel; Dibesh Karmacharya; Jivan Shakya; Sulochana Manandhar; Santosh Panthi; Prajwola Karmacharya; Deepika Sitaula; Reenu Thapaliya; Prawachan K C; Apurva Rai; Sameer Dixit
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

Review 3.  Viral Hepatitis in Nepal: Past, Present, and Future.

Authors:  Ananta Shrestha
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09

Review 4.  Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973-2017).

Authors:  Marcelo Contardo Moscoso Naveira; Komal Badal; Jagadish Dhakal; Neichu Angami Mayer; Bina Pokharel; Ruben Frank Del Prado
Journal:  Hepatol Med Policy       Date:  2018-09-06

5.  Direct-Acting Antivirals in the Treatment of Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) Co-infected Patients: Real-Life Experience From Nepal.

Authors:  Sudhamshu Kc; Niyanta Karki; Dilip Sharma; Sandip Khadka; Pratap S Tiwari
Journal:  Cureus       Date:  2021-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.